Exagen Inc.: President and CEO John Aballi sold 34,294 shares

What happened John Aballi, president and CEO, sold 34,294 shares at $7.87 per share on Oct 16, 2026, for $269,791. The filing lists the transaction as an open market or private sale (S).

Key details

• Transaction date and price: Oct 16, 2026 — 34,294 shares at $7.87 per share.
• Shares owned after the transaction: the filing does not report shares owned after the transaction.
• Footnote F1: the sale was to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units; the sale was mandated by the issuer's tax withholding process and was not a discretionary transaction by the reporting person.
• Filing date: Oct 19, 2026. The filing does not indicate it was filed late.

Why it may matter

• The filing indicates this was a sell-to-cover tax withholding transaction tied to RSU vesting, not an options exercise or a gift. The filing does not show why the insider traded or why the company acted.